<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Review The Role of Dendritic Cells in TB and HIV" exact="Infection" post="AbrahemRachel1https://orcid.org/0000-0002-7985-7343ChiangEmerald1HaquangJoseph1NhamAmy1https://orcid.org/0000-0003-2596-8176TingYu-Sam1https://orcid.org/0000-0002-2586-1160VenketaramanVishwanath12*[1], rachel.abrahem@westernu.eduemerald.chiang@westernu.edujoseph.haquang@westernu.eduamy.nham@westernu.eduyusam.ting@westernu.edu[2], *Correspondence: vvenketaraman@westernu.edu; Tel.: +1-909-706-3736; Fax: +1-909-469-5698 epub:"/>
 <result pre="increases the risk of susceptibility of infections, such as Mycobacterium" exact="tuberculosis" post="(M. tb), and the survival of the human immunodeficiency"/>
 <result pre="Mycobacterium tuberculosis (M. tb), and the survival of the human" exact="immunodeficiency" post="virus (HIV). The altered response of dendritic cells leads"/>
 <result pre="(Th1), Th2, Regulatory T cells (Tregs), and Th17 cells in" exact="tuberculosis" post="(TB) infections due to a diminishment of cytokine release"/>
 <result pre="Regulatory T cells (Tregs), and Th17 cells in tuberculosis (TB)" exact="infections" post="due to a diminishment of cytokine release from these"/>
 <result pre="to a diminishment of cytokine release from these APCs, while" exact="HIV infection" post="leads to DC maturation, allowing DCs to migrate to"/>
 <result pre="a diminishment of cytokine release from these APCs, while HIV" exact="infection" post="leads to DC maturation, allowing DCs to migrate to"/>
 <result pre="individuals with TB and HIV. dendritic cells HIV TB Mycobacterium" exact="tuberculosis" post="immune responses 1. Incidence and Epidemiology of Tuberculosis Tuberculosis"/>
 <result pre="TB Mycobacterium tuberculosis immune responses 1. Incidence and Epidemiology of" exact="Tuberculosis" post="Tuberculosis (TB) is a respiratory infection that originates from"/>
 <result pre="Mycobacterium tuberculosis immune responses 1. Incidence and Epidemiology of Tuberculosis" exact="Tuberculosis" post="(TB) is a respiratory infection that originates from the"/>
 <result pre="1. Incidence and Epidemiology of Tuberculosis Tuberculosis (TB) is a" exact="respiratory" post="infection that originates from the bacteria Mycobacterium tuberculosis (M."/>
 <result pre="Incidence and Epidemiology of Tuberculosis Tuberculosis (TB) is a respiratory" exact="infection" post="that originates from the bacteria Mycobacterium tuberculosis (M. tb)."/>
 <result pre="is a respiratory infection that originates from the bacteria Mycobacterium" exact="tuberculosis" post="(M. tb). TB is recognized as one of the"/>
 <result pre="TB is recognized as one of the top 10 leading" exact="infectious" post="killers globally; it is also the most common opportunistic"/>
 <result pre="leading infectious killers globally; it is also the most common" exact="opportunistic infection" post="and a contributing cause of death for HIV patients."/>
 <result pre="infectious killers globally; it is also the most common opportunistic" exact="infection" post="and a contributing cause of death for HIV patients."/>
 <result pre="million deaths [1]. According to the World Health Organizationâ€™s Annual" exact="Tuberculosis" post="Report in 2019, the highest estimated total incidence of"/>
 <result pre="Health Organizationâ€™s Annual Tuberculosis Report in 2019, the highest estimated" exact="total" post="incidence of TB was in Southeast Asia, with 4,370,000"/>
 <result pre="comorbidities and factors that suppress the immune system, such as" exact="uncontrolled" post="diabetes, HIV infection, chronic renal failure, and use of"/>
 <result pre="factors that suppress the immune system, such as uncontrolled diabetes," exact="HIV infection," post="chronic renal failure, and use of immunosuppressive drugs, are"/>
 <result pre="suppress the immune system, such as uncontrolled diabetes, HIV infection," exact="chronic" post="renal failure, and use of immunosuppressive drugs, are at"/>
 <result pre="the immune system, such as uncontrolled diabetes, HIV infection, chronic" exact="renal failure," post="and use of immunosuppressive drugs, are at higher risk"/>
 <result pre="use of immunosuppressive drugs, are at higher risk for contracting" exact="primary" post="M. tb infection and undergoing reactivation of latent M."/>
 <result pre="drugs, are at higher risk for contracting primary M. tb" exact="infection" post="and undergoing reactivation of latent M. tb infection [2]."/>
 <result pre="M. tb infection and undergoing reactivation of latent M. tb" exact="infection" post="[2]. Furthermore, social determinants of health, including poverty, undernutrition,"/>
 <result pre="for HIV, and smoking, lead to a higher M. tb" exact="disease" post="burden and, thus, concentrate the disease in socio-economically disadvantaged"/>
 <result pre="a higher M. tb disease burden and, thus, concentrate the" exact="disease" post="in socio-economically disadvantaged countries [3]. In developing regions, such"/>
 <result pre="disadvantaged countries [3]. In developing regions, such as Sub-Saharan Africa," exact="limited" post="access to ART increases the susceptibility to HIV and"/>
 <result pre="such as Sub-Saharan Africa, limited access to ART increases the" exact="susceptibility to" post="HIV and other co-infections most commonly seen with TB"/>
 <result pre="mortality if ART is started early [6]. 2. Pathophysiology of" exact="Tuberculosis" post="Initial infection with M. tb involves the inhalation of"/>
 <result pre="ART is started early [6]. 2. Pathophysiology of Tuberculosis Initial" exact="infection" post="with M. tb involves the inhalation of aerosolized infectious"/>
 <result pre="Initial infection with M. tb involves the inhalation of aerosolized" exact="infectious" post="droplets containing the pathogen, which travel down the respiratory"/>
 <result pre="aerosolized infectious droplets containing the pathogen, which travel down the" exact="respiratory" post="tract to infect the lungsâ€™ alveoli. Thereafter, M. tb"/>
 <result pre="and suppresses the M. tb, instead of completely clearing the" exact="infection" post="[7]. In these granulomas, mature macrophages fuse to form"/>
 <result pre="and cytotoxic CD8 T cells are also recruited to the" exact="granuloma" post="via cytokine mediation, leading to further containment of the"/>
 <result pre="in a non-replicating state. The contained M. tb within a" exact="granuloma" post="in the lungs is referred to as latent tuberculosis"/>
 <result pre="a granuloma in the lungs is referred to as latent" exact="tuberculosis" post="(LTBI). In immunocompromised individuals, a breakdown of immune responses"/>
 <result pre="An immune-compromised state promotes liquefaction of the caseum in the" exact="granuloma" post="and bacterial replication, thereby promoting cavity formation and the"/>
 <result pre="state promotes liquefaction of the caseum in the granuloma and" exact="bacterial" post="replication, thereby promoting cavity formation and the release of"/>
 <result pre="tb to the exterior during coughing, causing spread of the" exact="infection" post="to other parts of the lungs [10]. Active M."/>
 <result pre="bacterium [11]. 3. Incidence and Epidemiology of HIV The human" exact="immunodeficiency" post="virus (HIV) is a species of Lentivirus belonging to"/>
 <result pre="Lentivirus belonging to the family of Retroviridae and is the" exact="primary" post="infectious agent that is responsible for causing acquired immunodeficiency"/>
 <result pre="belonging to the family of Retroviridae and is the primary" exact="infectious" post="agent that is responsible for causing acquired immunodeficiency syndrome"/>
 <result pre="is the primary infectious agent that is responsible for causing" exact="acquired immunodeficiency syndrome" post="(AIDS) [12,13]. The major modes of transmission of HIV"/>
 <result pre="the primary infectious agent that is responsible for causing acquired" exact="immunodeficiency" post="syndrome (AIDS) [12,13]. The major modes of transmission of"/>
 <result pre="primary infectious agent that is responsible for causing acquired immunodeficiency" exact="syndrome" post="(AIDS) [12,13]. The major modes of transmission of HIV"/>
 <result pre="contributions to regional epidemics [14]. According to data from the" exact="Joint" post="United Nations Program on HIV/AIDS (UNAIDS), there are approximately"/>
 <result pre="According to data from the Joint United Nations Program on" exact="HIV/AIDS" post="(UNAIDS), there are approximately 38 million people living with"/>
 <result pre="children. Since its discovery in 1983, the incidence of HIV" exact="infections" post="has been reduced by 40% over the years with"/>
 <result pre="depletion of CD4+ T lymphocytes [18]. Cells residing within the" exact="epithelial" post="surfaces are the initial targets for HIV after mucosal"/>
 <result pre="surface envelope glycoprotein, gp120, must be able to bind to" exact="primary" post="receptors CD4 and a co-receptor CXCR4 or CCR5 for"/>
 <result pre="primary receptors CD4 and a co-receptor CXCR4 or CCR5 for" exact="viral" post="entry [19]. Once inside the cell, the virus will"/>
 <result pre="and will induce a cellular immune response and synthesis of" exact="viral" post="proteins. Within the first few weeks of symptomatic primary"/>
 <result pre="synthesis of viral proteins. Within the first few weeks of" exact="symptomatic" post="primary infection, viremia develops accompanied by symptoms in some"/>
 <result pre="of viral proteins. Within the first few weeks of symptomatic" exact="primary" post="infection, viremia develops accompanied by symptoms in some patients."/>
 <result pre="symptoms in some patients. During the first few weeks of" exact="acute" post="HIV infection there are high levels of replicating virus"/>
 <result pre="in some patients. During the first few weeks of acute" exact="HIV infection" post="there are high levels of replicating virus in the"/>
 <result pre="some patients. During the first few weeks of acute HIV" exact="infection" post="there are high levels of replicating virus in the"/>
 <result pre="HIV to other individuals occurs during this period of early" exact="infection" post="[22], especially in those that engage in risky behaviors"/>
 <result pre="with the development of a cellular immune response. Soon after," exact="secondary" post="phase, also known as asymptomatic period or clinical latency,"/>
 <result pre="asymptomatic period or clinical latency, represents a period of ongoing" exact="viral" post="replication that is unrecognized by the immune system. The"/>
 <result pre="pathogenic ability in the human host [24]. HIV-2 has a" exact="lower" post="infectivity, longer asymptomatic phase, and slower progression to AIDS"/>
 <result pre="envelope glycoprotein that binds to co-receptor CD4, but at a" exact="lower" post="affinity than HIV-1, possibly contributing to the differences seen"/>
 <result pre="or mature form [29]. The immature form is found in" exact="peripheral" post="tissues, which are responsible for detecting pathogens or injured"/>
 <result pre="for clearing pathogens as well as inducing tissue inflammation in" exact="autoimmune disease" post="[35]. With such a wide range of immune responses,"/>
 <result pre="clearing pathogens as well as inducing tissue inflammation in autoimmune" exact="disease" post="[35]. With such a wide range of immune responses,"/>
 <result pre="of immune responses, DCs also have a function to prevent" exact="autoimmune" post="reactions. This is achieved by inducing the formation and"/>
 <result pre="for maintaining self-tolerance and suppressing pathological immune responses by the" exact="clonal" post="deletion of self-reactive T cells [36] (Figure 1). Within"/>
 <result pre="as well as having a common macrophage precursor from the" exact="adult" post="fetal liver [37,38]. The DC characteristics include the ability"/>
 <result pre="Dendritic Cells CD4+ T cells are the major targets of" exact="HIV infection," post="although DCs may play a large part as they"/>
 <result pre="cell infection, and antigen presentation [39]. HIV must overcome the" exact="epithelial" post="barrier within the genital tract to reach immune target"/>
 <result pre="the genital tract to reach immune target cells beneath the" exact="epithelial" post="lining, where DCs are one of the first immune"/>
 <result pre="the virus [40,41]. DCs are capable of binding to the" exact="viral" post="envelope glycoprotein gp120 present on HIV-1 through high expression"/>
 <result pre="in contact with the HIV virus. LCs are resistant to" exact="HIV infection" post="by binding to the viral envelope glycoprotein gp160 through"/>
 <result pre="contact with the HIV virus. LCs are resistant to HIV" exact="infection" post="by binding to the viral envelope glycoprotein gp160 through"/>
 <result pre="LCs are resistant to HIV infection by binding to the" exact="viral" post="envelope glycoprotein gp160 through langerin, which leads to the"/>
 <result pre="which leads to the endocytosis of the virus and prevents" exact="infection" post="[42]. However, LCs also express the HIV entry receptors"/>
 <result pre="which mediates the fusion of gp160 and leads to productive" exact="infection" post="of the cell [42]. This can lead to transmission"/>
 <result pre="This can lead to transmission and rapid spread of the" exact="infection" post="to CD4+ T cells through cell-to-cell interactions [42]. Considering"/>
 <result pre="of Tregs compared to HIV-primed monocyte-derived DCs [43]. However, HIV-1" exact="infection" post="in LCs has been a source of controversy because"/>
 <result pre="likely possible reservoir and source of HIV-1 transmission in the" exact="female" post="genital tract, rather than LCs [44]. Preferential infection of"/>
 <result pre="in the female genital tract, rather than LCs [44]. Preferential" exact="infection" post="of VEDCs is due to their expression of CCR5,"/>
 <result pre="expression of CCR5, the receptor that a majority of new" exact="infections" post="by HIV-1 utilizes, as opposed to CXCR4 [45]. VEDCs"/>
 <result pre="binding [47]. A broad division of DCs is found in" exact="peripheral" post="blood, myeloid DCs (MDCs) and plasmacytoid DCs (pDCs) are"/>
 <result pre="DCs (MDCs) and plasmacytoid DCs (pDCs) are also susceptible to" exact="infection" post="with HIV. MDCs are more frequently found and can"/>
 <result pre="and CCR5 and, depending on expression of CLRs, can mediate" exact="infection" post="through fusion with the cell membrane [40]. Following binding,"/>
 <result pre="the cell membrane [40]. Following binding, activation of DCs upon" exact="HIV infection" post="is unclear. HIV is able to escape detection from"/>
 <result pre="cell membrane [40]. Following binding, activation of DCs upon HIV" exact="infection" post="is unclear. HIV is able to escape detection from"/>
 <result pre="to escape detection from MDCs, resulting in the avoidance of" exact="viral" post="nucleic acid coming in contact with pattern recognition receptors,"/>
 <result pre="accessory protein, vpx, in its genome. Without vpx, SAMHD1 inhibits" exact="viral" post="replication at the level of reverse transcription, therefore enabling"/>
 <result pre="has been conflicting data showing the activation of DCs upon" exact="HIV infection." post="Studies have shown that viral replication is inhibited, allowing"/>
 <result pre="activation of DCs upon HIV infection. Studies have shown that" exact="viral" post="replication is inhibited, allowing HIV to escape detection, whereas"/>
 <result pre="HIV to escape detection, whereas other studies have shown increased" exact="viral" post="replication stimulating an immune response. In regards to the"/>
 <result pre="are upregulated and DCs can migrate from the periphery to" exact="secondary" post="lymphoid organs [48]. Upon arrival at lymphoid tissues in"/>
 <result pre="It has been shown that DCs can undergo maturation by" exact="viral infection" post="or by cytokines in the microenvironment during migration and"/>
 <result pre="has been shown that DCs can undergo maturation by viral" exact="infection" post="or by cytokines in the microenvironment during migration and"/>
 <result pre="migration and then present HIV antigens to T cells in" exact="secondary" post="lymphoid tissues and initiate an immune response [53]. Other"/>
 <result pre="initiate an immune response [53]. Other studies have demonstrated that" exact="infection" post="of HIV on DCs with different stimuli can lead"/>
 <result pre="is well known that immature DCs are more susceptible to" exact="HIV infection" post="in comparison to mature DCs likely due to CCR5"/>
 <result pre="well known that immature DCs are more susceptible to HIV" exact="infection" post="in comparison to mature DCs likely due to CCR5"/>
 <result pre="novo replication of HIV [57]. Conversely, other studies have shown" exact="partial" post="maturation of DCs that is mediated by abnormal or"/>
 <result pre="partial maturation of DCs that is mediated by abnormal or" exact="partial" post="up-regulation of cell maturation markers effecting binding of gp120"/>
 <result pre="to monocyte-derived DCs [58]. It has also been demonstrated that" exact="HIV infection" post="can actively suppress DC maturation by inhibiting TLR-induced maturation"/>
 <result pre="monocyte-derived DCs [58]. It has also been demonstrated that HIV" exact="infection" post="can actively suppress DC maturation by inhibiting TLR-induced maturation"/>
 <result pre="to better understand their immune function, and how they influence" exact="infection" post="with HIV and other pathogens, may lead to novel"/>
 <result pre="lead to novel insight to develop new strategies to prevent" exact="HIV infection" post="of DCs. 7. Th1 vs. Th2 in Context of"/>
 <result pre="to novel insight to develop new strategies to prevent HIV" exact="infection" post="of DCs. 7. Th1 vs. Th2 in Context of"/>
 <result pre="critical effector subtype because M. tb is primarily an intracellular" exact="infection" post="as opposed to Th2, which is typically significant in"/>
 <result pre="in extra-cellular parasitic infections. Th1 cells clear the M. tb" exact="infection" post="by their secretion of IFN-Î³, which activates macrophages and"/>
 <result pre="via antimicrobial peptides, perforin, and granulysin [65]. Accordingly, patients with" exact="pulmonary" post="TB infections have been shown to have higher Th1:Th2"/>
 <result pre="peptides, perforin, and granulysin [65]. Accordingly, patients with pulmonary TB" exact="infections" post="have been shown to have higher Th1:Th2 ratios [66]."/>
 <result pre="required for Th1 polarization and down-stream effects result in increased" exact="susceptibility to" post="M. tb infection [67]. These findings indicate that the"/>
 <result pre="and down-stream effects result in increased susceptibility to M. tb" exact="infection" post="[67]. These findings indicate that the Th1 subclass plays"/>
 <result pre="Th1 cellsâ€™ role in inhibiting M. tb infections. Interestingly, in" exact="chronic" post="HIV-1 infection, HIV causes the Th1 subclass to switch"/>
 <result pre="the source of their activation, Th1 cells [74]. M. tb" exact="infection" post="highly relies on the Th1 response for clearance of"/>
 <result pre="Th1 response for clearance of the infection. In addition, HIV-1" exact="infection" post="and the progression to full-blown AIDS is recognized to"/>
 <result pre="levels. Low CD4+ T-cell counts lead to increased risk for" exact="opportunistic infections," post="and M. tb is often one of the first"/>
 <result pre="and M. tb is often one of the first severe" exact="opportunistic infections" post="acquired [78]. Collectively, a shift to the Th2 subtype"/>
 <result pre="M. tb is often one of the first severe opportunistic" exact="infections" post="acquired [78]. Collectively, a shift to the Th2 subtype"/>
 <result pre="tb is often one of the first severe opportunistic infections" exact="acquired" post="[78]. Collectively, a shift to the Th2 subtype and"/>
 <result pre="the activation and expansion of self-reactive T cells, which prevents" exact="autoimmune disease" post="[80]. Induction of Tregs occurs generally in central and"/>
 <result pre="activation and expansion of self-reactive T cells, which prevents autoimmune" exact="disease" post="[80]. Induction of Tregs occurs generally in central and"/>
 <result pre="disease [80]. Induction of Tregs occurs generally in central and" exact="peripheral" post="tolerance, with those formed in the periphery being mediated"/>
 <result pre="Upon formation of a granuloma, Tregs infiltrate the site of" exact="infection" post="to regulate the increased immune response against M. tb"/>
 <result pre="the site of infection, with levels at the site of" exact="infection" post="being greater [84,85]. The relationship of Tregs in those"/>
 <result pre="is not clearly understood as some studies have shown a" exact="deficiency" post="of Tregs following HIV infection while others have shown"/>
 <result pre="as some studies have shown a deficiency of Tregs following" exact="HIV infection" post="while others have shown an increase [64,86,87]. However, a"/>
 <result pre="some studies have shown a deficiency of Tregs following HIV" exact="infection" post="while others have shown an increase [64,86,87]. However, a"/>
 <result pre="Foxp3 expressing CD4 T cells during the early stages of" exact="HIV infection" post="peripherally thus contributing to increased immune response leading to"/>
 <result pre="expressing CD4 T cells during the early stages of HIV" exact="infection" post="peripherally thus contributing to increased immune response leading to"/>
 <result pre="permissive effect on HIV-1 replication [87]. Upon progression of the" exact="HIV infection," post="an upregulation in both levels of Tregs and Foxp3"/>
 <result pre="Tregs, further compromising the immune system and increasing the individualâ€™s" exact="susceptibility to" post="infection by M. tb [87]. However, due to the"/>
 <result pre="compromising the immune system and increasing the individualâ€™s susceptibility to" exact="infection" post="by M. tb [87]. However, due to the conflicting"/>
 <result pre="and the inflammatory response, including protecting against extracellular pathogens during" exact="autoimmune diseases" post="[88,89]. Th17 cells secrete IL-17, which serves as a"/>
 <result pre="as a chemoattractant to recruit neutrophils to the area of" exact="infection" post="[90,91]. Differentiation, stabilization, and amplification of Th17 cells is"/>
 <result pre="is an important part in the protection of the intestinal" exact="mucosa" post="from pathogens [94]. HIV infection can be characterized as"/>
 <result pre="in the protection of the intestinal mucosa from pathogens [94]." exact="HIV infection" post="can be characterized as loss of mucosal CD4+ T"/>
 <result pre="the protection of the intestinal mucosa from pathogens [94]. HIV" exact="infection" post="can be characterized as loss of mucosal CD4+ T"/>
 <result pre="the earliest stages of transmission in cases of macaque simian" exact="immunodeficiency" post="virus with Th17 markers CCR6 and RORÎ³t being initial"/>
 <result pre="and RORÎ³t being initial targets [96]. This permissive effect of" exact="infection" post="on Th17 cells is likely due to multiple factors"/>
 <result pre="tissues as well as its contribution to the persistence of" exact="HIV infection," post="especially during antiretroviral therapy, poses Th17 cells as a"/>
 <result pre="a potential target for immunotherapy [97]. Studies suggest that during" exact="HIV infection," post="Th17 cells are unable to express IL-17 and lose"/>
 <result pre="and lose ability to be maintained by IL-23 [98]. This" exact="deficiency" post="and impaired function of Th17 cells depletes the immune"/>
 <result pre="increased translocation of microbes across the intestinal epithelium into the" exact="systemic" post="circulation [90]. Taken into consideration in the context of"/>
 <result pre="in the context of M. tb and HIV coinfection, the" exact="respiratory" post="mucosal defense towards inhaled M. tb is compromised in"/>
 <result pre="respiratory mucosal defense towards inhaled M. tb is compromised in" exact="HIV infection" post="largely due to this loss of Th17 cells. In"/>
 <result pre="mucosal defense towards inhaled M. tb is compromised in HIV" exact="infection" post="largely due to this loss of Th17 cells. In"/>
 <result pre="resulting in immunosuppression, this results in advancement of active TB" exact="infection" post="[95]. 10. Glutathione with Dendritic Cells to Improve Immune"/>
 <result pre="which differentially regulate the genes encoding various pro-inflammatory cytokines [104]." exact="Severe" post="GSH depletion impairs the DCs ability to reduce antigen"/>
 <result pre="M. tb infection, exogenous GSH addition results in more robust" exact="granuloma" post="formation due to the enhancement of DC and cytokine"/>
 <result pre="the mechanism by which DC enhanced functionality against M. tb" exact="infection" post="occurs. Cystine, the rate-limiting factor in GSH biosynthesis, is"/>
 <result pre="evidenced with diminished levels of GSH in plasma, erythrocytes, and" exact="peripheral" post="blood mononuclear cells (PBMCs) of HIV+ individuals. This reduction"/>
 <result pre="The net result led to oxidative stress linked with increased" exact="viral" post="replication [114]. The addition of N-acetylcysteine (NAC), a prodrug"/>
 <result pre="formed to target dendrites, this could be a breakthrough for" exact="HIV infection." post="Previous studies have demonstrated that the loss of DCs"/>
 <result pre="conflict of interest. References References 1.HardingE.WHO global progress report on" exact="tuberculosis" post="eliminationLancet Respir. Med.202081910.1016/S2213-2600(19)30418-731706931 2.AhmadS.Pathogenesis, immunology, and diagnosis of latent"/>
 <result pre="eliminationLancet Respir. Med.202081910.1016/S2213-2600(19)30418-731706931 2.AhmadS.Pathogenesis, immunology, and diagnosis of latent mycobacterium" exact="tuberculosis" post="infectionClin. Dev. Immunol.2011201181494310.1155/2011/81494321234341 3.GlaziouP.SismanidisC.FloydK.RaviglioneM.Global epidemiology of tuberculosisCold Spring Harb."/>
 <result pre="CockK.M.KranzerK.LewisJ.J.ChurchyardG.J.Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated" exact="tuberculosis" post="in settings with limited health-care resourcesLancet Infect. Dis.20101048949810.1016/S1473-3099(10)70078-520610331 6.MartinsonN.A.HoffmannC.J.ChaissonR.E.Epidemiology"/>
 <result pre="therapy in the prevention of HIV-associated tuberculosis in settings with" exact="limited" post="health-care resourcesLancet Infect. Dis.20101048949810.1016/S1473-3099(10)70078-520610331 6.MartinsonN.A.HoffmannC.J.ChaissonR.E.Epidemiology of tuberculosis HIV recent"/>
 <result pre="in settings with limited health-care resourcesLancet Infect. Dis.20101048949810.1016/S1473-3099(10)70078-520610331 6.MartinsonN.A.HoffmannC.J.ChaissonR.E.Epidemiology of" exact="tuberculosis" post="HIV recent advances in understanding responsesProc. Am. Thorac. Soc.2011828829310.1513/pats.201010-064WR21653530"/>
 <result pre="understanding responsesProc. Am. Thorac. Soc.2011828829310.1513/pats.201010-064WR21653530 7.RamakrishnanL.Revisiting the role of the" exact="granuloma" post="in tuberculosisNat. Rev. Immunol.20121235236610.1038/nri321122517424 8.RussellD.G.CardonaP.J.KimM.J.AllainS.AltareF.Foamy macrophages the progression of"/>
 <result pre="tuberculosisNat. Rev. Immunol.20121235236610.1038/nri321122517424 8.RussellD.G.CardonaP.J.KimM.J.AllainS.AltareF.Foamy macrophages the progression of the human" exact="tuberculosis" post="granulomaNat. Immunol.20091094394810.1038/ni.178119692995 9.FlynnJ.L.ChanJ.Immunology of tuberculosisAnnu. Rev. Immunol.2001199312910.1146/annurev.immunol.19.1.9311244032 10.GuiradoE.SchlesingerL.S.Modeling the"/>
 <result pre="granulomaNat. Immunol.20091094394810.1038/ni.178119692995 9.FlynnJ.L.ChanJ.Immunology of tuberculosisAnnu. Rev. Immunol.2001199312910.1146/annurev.immunol.19.1.9311244032 10.GuiradoE.SchlesingerL.S.Modeling the mycobacterium" exact="tuberculosis" post="granuloma-the critical battlefield in host immunity and diseaseFront. Immunol.201349810.3389/fimmu.2013.0009823626591"/>
 <result pre="11.ForrelladM.A.KleppL.I.GioffreA.Sabio y GarciaJ.MorbidoniH.R.de la Paz SantangeloM.CataldiA.A.BigiF.Virulence factors of the mycobacterium" exact="tuberculosis" post="complexVirulence2013436610.4161/viru.2232923076359 12.ZhuangC.PannecouqueC.De ClercqE.ChenF.Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs):"/>
 <result pre="twenty yearsActa Pharm. Sin. B20201096197810.1016/j.apsb.2019.11.01032642405 13.collab: Blood, German Advisory CommitteeHuman" exact="Immunodeficiency" post="Virus (HIV)Transfus. Med. Hemother.20164320322210.1159/00044585227403093 14.FettigJ.SwaminathanM.MurrillC.S.KaplanJ.E.Global epidemiology of HIVInfect. Dis."/>
 <result pre="of a T-lymphotropic retrovirus from a patient at risk for" exact="acquired immune deficiency syndrome" post="(AIDS)Science198322086887110.1126/science.61891836189183 17.HIV/AIDSAvailable online: https://www.who.int/hiv/pub/guidelines/arv2013/intro/keyterms/en/(accessed on 7 July 2020) 18.ShawG.M.HunterE.HIV"/>
 <result pre="T-lymphotropic retrovirus from a patient at risk for acquired immune" exact="deficiency" post="syndrome (AIDS)Science198322086887110.1126/science.61891836189183 17.HIV/AIDSAvailable online: https://www.who.int/hiv/pub/guidelines/arv2013/intro/keyterms/en/(accessed on 7 July 2020)"/>
 <result pre="retrovirus from a patient at risk for acquired immune deficiency" exact="syndrome" post="(AIDS)Science198322086887110.1126/science.61891836189183 17.HIV/AIDSAvailable online: https://www.who.int/hiv/pub/guidelines/arv2013/intro/keyterms/en/(accessed on 7 July 2020) 18.ShawG.M.HunterE.HIV"/>
 <result pre="transmission events after acute/early HIV-1 infectionJ. Infect. Dis.200719595195910.1086/51208817330784 21.MillerW.C.RosenbergN.E.RutsteinS.E.PowersK.A.Role of" exact="acute" post="and early HIV infection in the sexual transmission of"/>
 <result pre="acute/early HIV-1 infectionJ. Infect. Dis.200719595195910.1086/51208817330784 21.MillerW.C.RosenbergN.E.RutsteinS.E.PowersK.A.Role of acute and early" exact="HIV infection" post="in the sexual transmission of HIVCurr. Opin. HIV AIDS2010527728210.1097/COH.0b013e32833a0d3a20543601"/>
 <result pre="HIV-1 infectionJ. Infect. Dis.200719595195910.1086/51208817330784 21.MillerW.C.RosenbergN.E.RutsteinS.E.PowersK.A.Role of acute and early HIV" exact="infection" post="in the sexual transmission of HIVCurr. Opin. HIV AIDS2010527728210.1097/COH.0b013e32833a0d3a20543601"/>
 <result pre="transmission of HIVCurr. Opin. HIV AIDS2010527728210.1097/COH.0b013e32833a0d3a20543601 22.VolzE.M.IonidesE.Romero-SeversonE.O.BrandtM.G.MokotoffE.KoopmanJ.S.HIV-1 transmission during early" exact="infection" post="in men who have sex with men: A phylodynamic"/>
 <result pre="men: A phylodynamic analysisPLoS Med.201310e100156810.1371/journal.pmed.100156824339751 23.PiersonT.McArthurJ.SilicianoR.F.Reservoirs for HIV-1: Mechanisms for" exact="viral" post="persistence in the presence of antiviral immune responses and"/>
 <result pre="model of a less virulent infectionAIDS Rev.201618445326936760 25.Campbell-YesufuO.T.GandhiR.T.Update on human" exact="immunodeficiency" post="virus (HIV)-2 infectionClin. Infect. Dis.20115278078710.1093/cid/ciq24821367732 26.Lugo-VillarinoG.CougouleC.MeunierE.RomboutsY.VerolletC.BalboaL.Editorial: The mononuclear phagocyte"/>
 <result pre="(HIV)-2 infectionClin. Infect. Dis.20115278078710.1093/cid/ciq24821367732 26.Lugo-VillarinoG.CougouleC.MeunierE.RomboutsY.VerolletC.BalboaL.Editorial: The mononuclear phagocyte system in" exact="infectious" post="diseaseFront. Immunol.201910144310.3389/fimmu.2019.0144331293593 27.OchandoJ.KwanW.H.GinhouxF.HutchinsonJ.A.HashimotoD.CollinM.The mononuclear phagocyte system in organ transplantationAm."/>
 <result pre="of dendritic cell and regulatory T cell functions against mycobacterium" exact="tuberculosis" post="infectionBiomed. Res. Int.2013201340282710.1155/2013/40282723762843 33.KimB.KimT.H.Fundamental role of dendritic cells in"/>
 <result pre="Intern. Med.20183348348910.3904/kjim.2016.22729502361 34.TerhuneJ.BerkE.CzernieckiB.J.Dendritic cell-Induced Th1 and Th17 cell differentiation for" exact="cancer" post="therapyVaccines2013152754910.3390/vaccines104052726344346 35.KornT.BettelliE.OukkaM.KuchrooV.K.IL-17 and Th17 cellsAnnu. Rev. Immunol.20092748551710.1146/annurev.immunol.021908.13271019132915 36.KushwahR.HuJ.Role of"/>
 <result pre="tug of warSpringer Semin. Immunopathol.20052630932810.1007/s00281-004-0178-y15609004 41.Rodriguez-GarciaM.ShenZ.BarrF.D.BoeschA.W.AckermanM.E.KappesJ.C.OchsenbauerC.WiraC.R.Dendritic cells from the human" exact="female" post="reproductive tract rapidly capture and respond to HIVMucosal Immunol.20171053154410.1038/mi.2016.7227579858"/>
 <result pre="HIV infectionJ. Dermatol. Sci.20178715916710.1016/j.jdermsci.2017.03.01528433429 44.Pena-CruzV.AgostoL.M.AkiyamaH.OlsonA.MoreauY.LarrieuxJ.R.HendersonA.GummuluruS.SagarM.HIV-1 replicates and persists in vaginal" exact="epithelial" post="dendritic cellsJ. Clin. Investig.20181283439344410.1172/JCI9894329723162 45.ConnorR.I.SheridanK.E.CeradiniD.ChoeS.LandauN.R.Change in coreceptor use correlates"/>
 <result pre="dendritic cellsJ. Clin. Investig.20181283439344410.1172/JCI9894329723162 45.ConnorR.I.SheridanK.E.CeradiniD.ChoeS.LandauN.R.Change in coreceptor use correlates with" exact="disease" post="progression in HIV-1--infected individualsJ. Exp. Med.199718562162810.1084/jem.185.4.6219034141 46.BertramK.M.BottingR.A.BaharlouH.RhodesJ.W.RanaH.GrahamJ.D.PatrickE.FletcherJ.PlastoT.M.TruongN.R.et al.Identification of"/>
 <result pre="it to CD4 T cellsFront. Immunol.20189271910.3389/fimmu.2018.0271930532754 53.WuL.KewalRamaniV.N.Dendritic-cell interactions with HIV:" exact="Infection" post="and viral disseminationNat. Rev. Immunol.2006685986810.1038/nri196017063186 54.HarmanA.N.WilkinsonJ.ByeC.R.BosnjakL.SternJ.L.NicholleM.LaiJ.CunninghamA.L.HIV induces maturation of"/>
 <result pre="CD4 T cellsFront. Immunol.20189271910.3389/fimmu.2018.0271930532754 53.WuL.KewalRamaniV.N.Dendritic-cell interactions with HIV: Infection and" exact="viral" post="disseminationNat. Rev. Immunol.2006685986810.1038/nri196017063186 54.HarmanA.N.WilkinsonJ.ByeC.R.BosnjakL.SternJ.L.NicholleM.LaiJ.CunninghamA.L.HIV induces maturation of monocyte-derived dendritic"/>
 <result pre="of contaminating cellular proteins found in purified HIV-1 preparationsVirology199723013414410.1006/viro.1997.84999126269 56.CavroisM.NeidlemanJ.KreisbergJ.F.FenardD.CallebautC.GreeneW.C.Human" exact="immunodeficiency" post="virus fusion to dendritic cells declines as cells matureJ."/>
 <result pre="57.MercierS.K.DonaghyH.BottingR.A.TurvilleS.G.HarmanA.N.NasrN.JiH.KusebauchU.MendozaL.ShteynbergD.et al.The microvesicle component of HIV-1 inocula modulates dendritic cell" exact="infection" post="and maturation and enhances adhesion to and activation of"/>
 <result pre="enhances adhesion to and activation of T lymphocytesPLoS Pathog.20139e100370010.1371/annotation/059beb14-db84-4836-9fef-ec351946025a24204260 58.FantuzziL.PurificatoC.DonatoK.BelardelliF.GessaniS.Human" exact="immunodeficiency" post="virus type 1 gp120 induces abnormal maturation and functional"/>
 <result pre="to and activation of T lymphocytesPLoS Pathog.20139e100370010.1371/annotation/059beb14-db84-4836-9fef-ec351946025a24204260 58.FantuzziL.PurificatoC.DonatoK.BelardelliF.GessaniS.Human immunodeficiency virus" exact="type 1" post="gp120 induces abnormal maturation and functional alterations of dendritic"/>
 <result pre="dendritic cellsJ. Immunol.2013190667910.4049/jimmunol.120077923183897 63.Bermejo-JambrinaM.EderJ.HelgersL.C.HertoghsN.NijmeijerB.M.StunnenbergM.GeijtenbeekT.B.H.C-type lectin receptors in antiviral immunity and" exact="viral" post="escapeFront. Immunol.2018959010.3389/fimmu.2018.0059029632536 64.WeissL.Donkova-PetriniV.CaccavelliL.BalboM.CarbonneilC.LevyY.Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory"/>
 <result pre="lectin receptors in antiviral immunity and viral escapeFront. Immunol.2018959010.3389/fimmu.2018.0059029632536 64.WeissL.Donkova-PetriniV.CaccavelliL.BalboM.CarbonneilC.LevyY.Human" exact="immunodeficiency" post="virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress"/>
 <result pre="Th1 to Th2 cytokine shift during the course of HIV-1" exact="infection" post="using cytoplasmic cytokine detection on single cell level by"/>
 <result pre="replicate preferentially in TH2 and TH0 cellsScience199426524424810.1126/science.80231428023142 71.YegorovS.JoagV.GaliwangoR.M.GoodS.V.OkechB.KaulR.Impact of endemic" exact="infections" post="on HIV susceptibility in sub-saharan africaTrop. Dis. Travel Med."/>
 <result pre="(Th1) and T helper 2 (Th2) cytokine balance during HIV-1" exact="infection" post="are indicative of an allergic response to viral proteins"/>
 <result pre="during HIV-1 infection are indicative of an allergic response to" exact="viral" post="proteins that may be reversed by Th2 cytokine inhibitors"/>
 <result pre="3S201S20710.1086/65149220397949 80.SakaguchiS.OnoM.SetoguchiR.YagiH.HoriS.FehervariZ.ShimizuJ.TakahashiT.NomuraT.Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and" exact="autoimmune" post="diseaseImmunol. Rev.200621282710.1111/j.0105-2896.2006.00427.x16903903 81.AngeramiM.T.SuarezG.V.VecchioneM.B.LauferN.AmeriD.BenG.PerezH.SuedO.SalomonH.QuirogaM.F.Expansion of CD25-negative forkhead box P3-positive T"/>
 <result pre="CD25-negative forkhead box P3-positive T cells during HIV and mycobacterium" exact="tuberculosis" post="InfectionFront. Immunol.2017852810.3389/fimmu.2017.0052828536578 82.FiorentinoD.F.ZlotnikA.VieiraP.MosmannT.R.HowardM.MooreK.W.Oâ€™GarraA.IL-10 acts on the antigen-presenting cell to"/>
 <result pre="cellsJ. Immunol.1991146344434511827484 83.ParkashO.AgrawalS.Madhan KumarM.T regulatory cells: Achillesâ€™ heel of mycobacterium" exact="tuberculosis" post="infection?Immunol. Res.20156238639810.1007/s12026-015-8654-025948475 84.Guyot-RevolV.InnesJ.A.HackforthS.HinksT.LalvaniA.Regulatory T cells are expanded in blood"/>
 <result pre="infection?Immunol. Res.20156238639810.1007/s12026-015-8654-025948475 84.Guyot-RevolV.InnesJ.A.HackforthS.HinksT.LalvaniA.Regulatory T cells are expanded in blood and" exact="disease" post="sites in patients with tuberculosisAm. J. Respir. Crit. Care"/>
 <result pre="AlamiM.N.SadakA.BurantC.Henry BoomW.El AouadR.CanadayD.H.SeghrouchniF.Immune activation and regulatory T cells in mycobacterium" exact="tuberculosis" post="infected lymph nodesBMC Immunol.2018193310.1186/s12865-018-0266-830409122 86.ApoilP.A.PuissantB.RoubinetF.AbbalM.MassipP.BlancherA.FOXP3 mRNA levels are decreased"/>
 <result pre="infected lymph nodesBMC Immunol.2018193310.1186/s12865-018-0266-830409122 86.ApoilP.A.PuissantB.RoubinetF.AbbalM.MassipP.BlancherA.FOXP3 mRNA levels are decreased in" exact="peripheral" post="blood CD4+ lymphocytes from HIV-positive patientsJ. Acquir. Immune Defic."/>
 <result pre="mRNA levels are decreased in peripheral blood CD4+ lymphocytes from" exact="HIV-positive" post="patientsJ. Acquir. Immune Defic. Syndr.20053938138510.1097/01.qai.0000169662.30783.2d16010156 87.ToorJ.S.SinghS.SharmaA.AroraS.K.Mycobacterium tuberculosis modulates the"/>
 <result pre="CD4+ lymphocytes from HIV-positive patientsJ. Acquir. Immune Defic. Syndr.20053938138510.1097/01.qai.0000169662.30783.2d16010156 87.ToorJ.S.SinghS.SharmaA.AroraS.K.Mycobacterium" exact="tuberculosis" post="modulates the gene interactions to activate the HIV replication"/>
 <result pre="the gene interactions to activate the HIV replication and faster" exact="disease" post="progression in a co-infected hostPLoS ONE20149e10681510.1371/journal.pone.010681525198707 88.LyadovaI.V.PanteleevA.V.Th1 and Th17"/>
 <result pre="Cells in Tuberculosis: Protection; Pathology; and BiomarkersMediat. Inflamm.2015201585450710.1155/2015/854507 89.MurrayL.W.SattiI.MeyerowitzJ.JonesM.WillbergC.B.UssherJ.E.GoedhalsD.HurstJ.PhillipsR.E.McShaneH.et al.Human" exact="immunodeficiency" post="virus infection impairs Th1 and Th17 mycobacterium tuberculosis-specific T-Cell"/>
 <result pre="in Tuberculosis: Protection; Pathology; and BiomarkersMediat. Inflamm.2015201585450710.1155/2015/854507 89.MurrayL.W.SattiI.MeyerowitzJ.JonesM.WillbergC.B.UssherJ.E.GoedhalsD.HurstJ.PhillipsR.E.McShaneH.et al.Human immunodeficiency" exact="virus infection" post="impairs Th1 and Th17 mycobacterium tuberculosis-specific T-Cell responsesJ. Infect."/>
 <result pre="Tuberculosis: Protection; Pathology; and BiomarkersMediat. Inflamm.2015201585450710.1155/2015/854507 89.MurrayL.W.SattiI.MeyerowitzJ.JonesM.WillbergC.B.UssherJ.E.GoedhalsD.HurstJ.PhillipsR.E.McShaneH.et al.Human immunodeficiency virus" exact="infection" post="impairs Th1 and Th17 mycobacterium tuberculosis-specific T-Cell responsesJ. Infect."/>
 <result pre="al.Human immunodeficiency virus infection impairs Th1 and Th17 mycobacterium tuberculosis-specific" exact="T-Cell" post="responsesJ. Infect. Dis.20182171782179210.1093/infdis/jiy05229546381 90.BixlerS.L.MattapallilJ.J.Loss and dysregulation of Th17 cells"/>
 <result pre="A dynamic balance regulated by the gut microbiomeFront. Immunol.2015663910.3389/fimmu.2015.0063926734006 95.KorbV.C.PhulukdareeA.LallooU.G.ChuturgoonA.A.MoodleyD.TB/HIV" exact="pleurisy" post="reduces Th17 lymphocyte proportion independent of the cytokine microenvironmentTuberculosis"/>
 <result pre="mechanismsJCI Insight20172e9323010.1172/jci.insight.93230 98.FernandesJ.R.BerthoudT.K.KumarA.AngelJ.B.IL-23 signaling in Th17 cells is inhibited by" exact="HIV infection" post="and is not restored by HAART: Implications for persistent"/>
 <result pre="Insight20172e9323010.1172/jci.insight.93230 98.FernandesJ.R.BerthoudT.K.KumarA.AngelJ.B.IL-23 signaling in Th17 cells is inhibited by HIV" exact="infection" post="and is not restored by HAART: Implications for persistent"/>
 <result pre="of class II MHC invariant chainImmunol. Lett.19944318919310.1016/0165-2478(94)90221-67721331 107.VignaliD.A.KuchrooV.K.IL-12 family cytokines:" exact="Immunological" post="playmakersNat. Immunol.20121372272810.1038/ni.236622814351 108.AgrawalA.KaushalP.AgrawalS.GollapudiS.GuptaS.Thimerosal induces TH2 responses via influencing cytokine"/>
 <result pre="dendritic cellsJ. Leukoc Biol.20078147448210.1189/jlb.070646717079650 109.TailleuxL.SchwartzO.HerrmannJ.L.PivertE.JacksonM.AmaraA.LegresL.DreherD.NicodL.P.GluckmanJ.C.et al.DC-SIGN is the major Mycobacterium" exact="tuberculosis" post="receptor on human dendritic cellsJ. Exp. Med.200319712112710.1084/jem.2002146812515819 110.AngeliniG.GardellaS.ArdyM.CirioloM.R.FilomeniG.Di TrapaniG.ClarkeF.SitiaR.RubartelliA.Antigen-presenting"/>
 <result pre="USA2002991491149610.1073/pnas.02263029911792859 111.BenharM.ShytajI.L.StamlerJ.S.SavarinoA.Dual targeting of the thioredoxin and glutathione systems in" exact="cancer" post="and HIVJ. Clin. Investig.20161261630163910.1172/JCI8533927135880 112.IvanovA.V.Valuev-EllistonV.T.IvanovaO.N.KochetkovS.N.StarodubovaE.S.BartoschB.IsaguliantsM.G.Oxidative Stress during HIV Infection:"/>
</results>
